Gilead Sciences Inc (XTER:GIS)
€ 120.5 +4.18 (+3.59%) Market Cap: 146.40 Bil Enterprise Value: 159.08 Bil PE Ratio: 18.29 PB Ratio: 7.09 GF Score: 78/100

Gilead Sciences Inc at Citi Global Healthcare Conference Transcript

Dec 02, 2025 / 04:15PM GMT
Release Date Price: €107.42 (+0.06%)
Unidentified Participant

Good morning. Welcome to the Citi Global Healthcare Conference continuing this morning. Next up we have Gilead Sciences, and with us today, we're pleased to have Andy Dickinson, CFO. Welcome.

Andrew Dickinson
Gilead Sciences Inc - Chief Financial Officer

Thank you. Thanks for having us again. I appreciate it.

Unidentified Participant

Of course. But we start this way. Maybe give a couple of minutes to give some opening remarks, and then we'll go over some questions.

Andrew Dickinson
Gilead Sciences Inc - Chief Financial Officer

Sure, yeah. Maybe four things to highlight as we start. One, we've had a terrific 2025 so far. You see that in our third quarter results. We increased our guidance for the year. So we can talk about that specifically. But a great, great first three quarters of the year carrying a lot of momentum in our business overall. You see, the second thing I would highlight is the really strong durable portfolio. So our base business led by our two

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot